Source: American Heart Journal. Unidade: FMRP
Subjects: BIOMARCADORES, INSUFICIÊNCIA CARDÍACA, PEPTÍDEO NATRIURÉTICO ATRIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSA, Priscila Raupp da et al. Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: the ReBIC-1 trial. American Heart Journal, v. 194, p. 125-131, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2017.08.012. Acesso em: 09 maio 2024.APA
Rosa, P. R. da, Rohde, L. E., Doebber, M., Ribeiro, A. L. P., Prado, D. P., Bertoldi, E. G., et al. (2017). Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: the ReBIC-1 trial. American Heart Journal, 194, 125-131. doi:10.1016/j.ahj.2017.08.012NLM
Rosa PR da, Rohde LE, Doebber M, Ribeiro ALP, Prado DP, Bertoldi EG, Figueiredo Neto JA de, Köhler I, Beck-da-Silva L, Danzmann LC, Moura LZ, Rover M, Simões MV, Sant'Anna RT, Biolo A. Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: the ReBIC-1 trial [Internet]. American Heart Journal. 2017 ; 194 125-131.[citado 2024 maio 09 ] Available from: https://doi.org/10.1016/j.ahj.2017.08.012Vancouver
Rosa PR da, Rohde LE, Doebber M, Ribeiro ALP, Prado DP, Bertoldi EG, Figueiredo Neto JA de, Köhler I, Beck-da-Silva L, Danzmann LC, Moura LZ, Rover M, Simões MV, Sant'Anna RT, Biolo A. Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: the ReBIC-1 trial [Internet]. American Heart Journal. 2017 ; 194 125-131.[citado 2024 maio 09 ] Available from: https://doi.org/10.1016/j.ahj.2017.08.012